U.S. markets close in 1 hour 14 minutes

Amryt Pharma plc (AMYT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.25-0.42 (-3.94%)
As of 2:42PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 8/1/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-6.81%
S&P500 52-Week Change 332.68%
52 Week High 315.44
52 Week Low 310.15
50-Day Moving Average 311.65
200-Day Moving Average 312.87

Share Statistics

Avg Vol (3 month) 383.21k
Avg Vol (10 day) 381k
Shares Outstanding 535.88M
Implied Shares Outstanding 6N/A
Float 5.93M
% Held by Insiders 10.00%
% Held by Institutions 143.02%
Shares Short (Jul 14, 2021) 4755.75k
Short Ratio (Jul 14, 2021) 415.96
Short % of Float (Jul 14, 2021) 4N/A
Short % of Shares Outstanding (Jul 14, 2021) 42.11%
Shares Short (prior month Jun 14, 2021) 4779.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -49.43%
Operating Margin (ttm)-2.73%

Management Effectiveness

Return on Assets (ttm)-0.61%
Return on Equity (ttm)-118.53%

Income Statement

Revenue (ttm)186.46M
Revenue Per Share (ttm)5.66
Quarterly Revenue Growth (yoy)8.70%
Gross Profit (ttm)91.19M
EBITDA -15.45M
Net Income Avi to Common (ttm)-92.17M
Diluted EPS (ttm)-2.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)118.52M
Total Cash Per Share (mrq)3.3
Total Debt (mrq)196.31M
Total Debt/Equity (mrq)361.10
Current Ratio (mrq)2.14
Book Value Per Share (mrq)1.51

Cash Flow Statement

Operating Cash Flow (ttm)23.44M
Levered Free Cash Flow (ttm)5.22M